Elevated tissue inhibitor of metalloproteinase-1 along with left atrium hypertrophy predict atrial fibrillation recurrence after catheter ablation
This study aimed to establish a model that predicts atrial fibrillation (AF) recurrence after catheter ablation using clinical risk factors and biomarkers. We used a prospective cohort study, including 230 consecutive persistent AF patients successfully treated with catheter ablation from January 20...
Main Authors: | Weiping Sun, Haiwei Li, Zefeng Wang, Qin Li, Haichu Wen, Yongquan Wu, Jie Du |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.1010443/full |
Similar Items
-
The new atrium /
by: 189532 Bednar, Michael J.
Published: (1986) -
The atrium comes of age /
by: 461953 Saxon, Richard
Published: (1993) -
The New Atrium /
by: Bednar, Michael J., author
Published: (1986) -
Correlation of matrix metalloproteinase 3 and matrix metalloproteinase 9 levels with non-motor symptoms in patients with Parkinson’s disease
by: Chuan Ze Liu, et al.
Published: (2022-08-01) -
Design principles of atrium buildings for the tropics /
by: Mohd. Hamdan Ahmad, Prof., 1964-, et al.
Published: (2000)